Multiple myeloma is a disease of elderly adults. Improvement in survival has occurred because of biological insights and novel agents. Therapeutic options involve choices today, thus have become more complex. Demographics have led to an increased number of elderly patients and age may be associated with a poorer outcome but is not the only prognostic predictor today.

中文翻译：

---

多发性骨髓瘤患者的老年评估和虚弱评分：个体化治疗所需的工具？

多发性骨髓瘤是一种老年人疾病。由于生物学见解和新药物的出现，生存率得到了改善。治疗选择涉及今天的选择，因此变得更加复杂。人口统计导致老年患者数量增加，年龄可能与较差的预后相关，但并不是当今唯一的预后预测因素。